Literature DB >> 6365754

Regulation of resistance to leprosy by chromosome 1 locus in the mouse.

E Skamene, P Gros, A Forget, P J Patel, M N Nesbitt.   

Abstract

Mice of different inbred strains vary in their resistance to intravenous infection with Mycobacterium lepraemurium (MLM). The mean survival time of MLM-infected A/J and DBA/2 mice is significantly longer than that of similarly infected C57BL/6 and BALB/c mice. The typing of AXB/BXA recombinant inbred strains (A = A/J,B = C57BL/6) for the trait of relative resistance/susceptibility to MLM revealed a perfect match with the strain distribution pattern of resistance/susceptibility to Mycobacterium bovis (BCG), the trait which is controlled by the Bcg (Ity, Lsh) locus on chromosome 1. The control, by this gene, of response to MLM was further confirmed by the demonstration that BALB/c-Bcgr congenic mice, which carry the DBA/2-derived Bcgr (resistant) allele on chromosome 1, are significantly more resistant to MLM infection than their BALB/c (Bcgs, susceptible) counterparts.

Entities:  

Mesh：

Year:  1984        PMID： 6365754     DOI： 10.1007/bf00387854

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


  25 in total

1.  Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse.

Authors:  D J Bradley; B A Taylor; J Blackwell; E P Evans; J Freeman
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

2.  The walls of Mycobacterium lepraemurium: chemistry and ultrastructure.

Authors:  P Draper
Journal:  J Gen Microbiol       Date:  1971-12

3.  Position on mouse chromosome 1 of a gene that controls resistance to Salmonella typhimurium.

Authors:  B A Taylor; A D O'Brien
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

4.  Susceptibility of inbred mice to Leishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities.

Authors:  C A Nacy; A H Fortier; M G Pappas; R R Henry
Journal:  Cell Immunol       Date:  1983-04-15       Impact factor: 4.868

5.  Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.

Authors:  M J Lefford; P J Patel; L W Poulter; G B Mackaness
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

6.  H-2 linkage control of resistance to subcutaneous infection with Mycobacterium lepraemurium.

Authors:  J Curtis; H O Adu; J L Turk
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).

Authors:  P Gros; E Skamene; A Forget
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

8.  Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro.

Authors:  C R Lissner; R N Swanson; A D O'Brien
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

9.  Effect of Mycobacterium bovis BCG vaccination upon Mycobacterium lepraemurium infection.

Authors:  M J Lefford; R Morgan; P S Logie
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

10.  Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice.

Authors:  J G Howard; C Hale; W L Chan-Liew
Journal:  Parasite Immunol       Date:  1980       Impact factor: 2.280
View more
  30 in total

1.  Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice.

Authors:  C Nauciel; E Ronco; J L Guenet; M Pla
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

Review 2.  Subline divergence within L.C. Strong's C3H and CBA inbred mouse strains. A review.

Authors:  A C Whitmore; S P Whitmore
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice.

Authors:  M Roberts; J Alexander; J M Blackwell
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Control of the Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria.

Authors:  M Denis; A Forget; M Pelletier; R Turcotte; E Skamene
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

Review 5.  Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice.

Authors:  E Buschman; A S Apt; B V Nickonenko; A M Moroz; M H Averbakh; E Skamene
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice.

Authors:  R J North; R LaCourse; L Ryan; P Gros
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade island.

Authors:  L Abel; F Demenais
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

8.  Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations.

Authors:  E V Davies; A M Singleton; J M Blackwell
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Influence of the Ity/Lsh/Bcg gene on the development of suppressor cell precursors in the early phase of the infection of mice with Mycobacterium lepraemurium.

Authors:  D Gosselin; R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice.

Authors:  M Brandely; P H Lagrange; B Hurtrel
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.